Allgemein Archives | Mursla Bio

Mursla Bio helps shape the standardisation of EV-based liquid biopsy for clinical use

Mursla Bio participates in a unique global initiative to standardise the clinical use of novel EV-based biomarkers for liquid biopsy

Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event

Showcase spotlights Mursla Bio’s first-in-class science and upcoming milestones for flagship product launch

Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023

Mursla Bio was selected to present at the largest pharmaceutical and biotech partnering event in Europe this Spring

Mursla Bio was selected by the UK Department of International Trade to represent UK excellence across the life sciences sector

Mursla Bio’s cutting edge expertise in extracellular vesicle biology is to be showcased at the world’s largest genomics event

Mursla adds seasoned executive with a wealth of experience in rapid growth and product commercialisation to leadership team

Novel technology further establishes Mursla Bio’s capabilities to uniquely analyse extracellular vesicle biology for clinical translation

Access to Roche Diagnostics’ expertise in the UK secured in recognition of Mursla’s differentiated value proposition for liquid biopsy